The company isn't content with just one area of focus; it's actively expanding into new verticals like injectables, peptides, ...

Aurobindo, that last year signed a deal with U.S. drugmaker MSD to manufacture one of their biologics products at its ...

Aurobindo Pharma has terminated a license agreement through its subsidiary Auro Vaccines with Hilleman Laboratories for ...

Hyderabad: Aurobindo Pharma has announced that Auro Vaccines Private Limited, a wholly owned step-down subsidiary of the ...

Aurobindo Pharma has terminated its licensing agreement with Hilleman Laboratories Singapore for a paediatric pentavalent ...

Aurobindo Pharma's subsidiary Auro Vaccines has terminated a license agreement with Singapore-based Hilleman Laboratories for ...

Aurobindo Pharma Ltd is quoting at Rs 1104, down 1% on the day as on 13:19 IST on the NSE. The stock jumped 5.96% in last one year as compared to a 2.05% rally in NIFTY and a 7.76% spurt in the Nifty ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Brokerages issued updated recommendations on Balkrishna Industries, Varun Beverages, and Aurobindo Pharma. Balkrishna sees ...

AUROBINDO PHARMA - TERMINATION OF LICENSE AGREEMENT WITH HILLEMAN LABORATORIES SINGAPORE PTE * AUROBINDO PHARMA - TERMINATION OF AGREEMENT BY AURO VACCINES ...

February 6, 2025 India's Aurobindo Pharma posts third-quarter profit drop on higher expenses Indian drugmaker Aurobindo Pharma reported a lower third-quarter profit on Thursday, as a spike in ...